GB201419109D0 - Incorporation of unnatural amino acids into proteins - Google Patents

Incorporation of unnatural amino acids into proteins

Info

Publication number
GB201419109D0
GB201419109D0 GBGB1419109.2A GB201419109A GB201419109D0 GB 201419109 D0 GB201419109 D0 GB 201419109D0 GB 201419109 A GB201419109 A GB 201419109A GB 201419109 D0 GB201419109 D0 GB 201419109D0
Authority
GB
United Kingdom
Prior art keywords
incorporation
proteins
amino acids
unnatural amino
unnatural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1419109.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB1419109.2A priority Critical patent/GB201419109D0/en
Publication of GB201419109D0 publication Critical patent/GB201419109D0/en
Priority to KR1020177014048A priority patent/KR102516695B1/ko
Priority to US15/521,103 priority patent/US10738339B2/en
Priority to CA2965085A priority patent/CA2965085A1/en
Priority to BR112017008108A priority patent/BR112017008108A2/pt
Priority to CN201580058784.6A priority patent/CN107002088B/zh
Priority to PCT/GB2015/053141 priority patent/WO2016066995A1/en
Priority to EP15794622.9A priority patent/EP3212799B1/en
Priority to JP2017519813A priority patent/JP6843044B2/ja
Priority to JP2020177605A priority patent/JP2021035374A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01026—Pyrrolysine-tRNAPyl ligase (6.1.1.26)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GBGB1419109.2A 2014-10-27 2014-10-27 Incorporation of unnatural amino acids into proteins Ceased GB201419109D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1419109.2A GB201419109D0 (en) 2014-10-27 2014-10-27 Incorporation of unnatural amino acids into proteins
JP2017519813A JP6843044B2 (ja) 2014-10-27 2015-10-21 非天然アミノ酸のタンパク質への組み込み
BR112017008108A BR112017008108A2 (pt) 2014-10-27 2015-10-21 incorporação de aminoácidos não naturais em proteínas
US15/521,103 US10738339B2 (en) 2014-10-27 2015-10-21 Use of eRF1 mutants in unnatural amino acid incorporation
CA2965085A CA2965085A1 (en) 2014-10-27 2015-10-21 Incorporation of unnatural amino acids into proteins
KR1020177014048A KR102516695B1 (ko) 2014-10-27 2015-10-21 단백질 내로의 비-천연 아미노산의 혼입
CN201580058784.6A CN107002088B (zh) 2014-10-27 2015-10-21 将非天然氨基酸掺入蛋白质中
PCT/GB2015/053141 WO2016066995A1 (en) 2014-10-27 2015-10-21 Incorporation of unnatural amino acids into proteins
EP15794622.9A EP3212799B1 (en) 2014-10-27 2015-10-21 Incorporation of unnatural amino acids into proteins
JP2020177605A JP2021035374A (ja) 2014-10-27 2020-10-22 非天然アミノ酸のタンパク質への組み込み

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1419109.2A GB201419109D0 (en) 2014-10-27 2014-10-27 Incorporation of unnatural amino acids into proteins

Publications (1)

Publication Number Publication Date
GB201419109D0 true GB201419109D0 (en) 2014-12-10

Family

ID=52103474

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1419109.2A Ceased GB201419109D0 (en) 2014-10-27 2014-10-27 Incorporation of unnatural amino acids into proteins

Country Status (9)

Country Link
US (1) US10738339B2 (enExample)
EP (1) EP3212799B1 (enExample)
JP (2) JP6843044B2 (enExample)
KR (1) KR102516695B1 (enExample)
CN (1) CN107002088B (enExample)
BR (1) BR112017008108A2 (enExample)
CA (1) CA2965085A1 (enExample)
GB (1) GB201419109D0 (enExample)
WO (1) WO2016066995A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6343604B2 (ja) 2012-05-18 2018-06-13 メディカル リサーチ カウンシル ＢＣＮ基を含むアミノ酸をコードする直交性コドンと、直交性ＰｙｌＲＳ合成酵素とを使用して、ＢＣＮ基を含むアミノ酸をポリペプチドに取り込む方法
GB2528227A (en) 2014-03-14 2016-01-20 Medical Res Council Cyclopropene amino acids and methods
WO2018044143A1 (ko) * 2016-09-05 2018-03-08 한국과학기술원 목적 단백질의 위치 특이적 변형이 시공간적으로 조절되는 마우스, 이의 제조방법 및 그 용도
CN106834349B (zh) * 2017-02-28 2019-12-13 中国人民解放军军事医学科学院 一种安全性提高的病毒基因递送系统
CN117286182A (zh) * 2017-06-02 2023-12-26 Ambrx公司 促进含非天然氨基酸的蛋白质产生的方法和组合物
CN119410679A (zh) * 2018-05-01 2025-02-11 Ambrx公司 一种用于优化抗体表达的方法
US20210356377A1 (en) * 2018-09-07 2021-11-18 Medimmune, Llc Methods Of Cell Selection
GB201817444D0 (en) 2018-10-26 2018-12-12 Res & Innovation Uk Methods and compositions
EP3696189A1 (en) * 2019-02-14 2020-08-19 European Molecular Biology Laboratory Means and methods for preparing engineered target proteins by genetic code expansion in a target protein selective manner
CN111718949B (zh) * 2019-03-19 2021-10-01 宁波鲲鹏生物科技有限公司 利用双质粒系统在蛋白中引入非天然氨基酸
CN111850020B (zh) * 2019-04-25 2021-05-07 苏州鲲鹏生物技术有限公司 利用质粒系统在蛋白中引入非天然氨基酸
CN111849929B (zh) * 2019-04-30 2021-05-11 苏州鲲鹏生物技术有限公司 高效引入赖氨酸衍生物的氨酰基—tRNA合成酶
GB201906775D0 (en) 2019-05-14 2019-06-26 Res & Innovation Uk Synthetic genome
TW202128996A (zh) * 2019-10-10 2021-08-01 美商史基普研究協會 用於活體內合成非天然多肽的組合物及方法
CN117881779A (zh) 2021-05-28 2024-04-12 英国研究与创新署 微生物及其用途
CN113481239A (zh) * 2021-07-01 2021-10-08 四川大学华西医院 一种通过Rosa26位点向细胞系中引入非天然氨基酸编码体系的方法及其细胞系
AU2022306337A1 (en) * 2021-07-07 2024-02-01 Ajinomoto Co., Inc. Method for secretory production of unnatural-amino-acid-containing protein
GB202110137D0 (en) 2021-07-14 2021-08-25 Res & Innovation Uk Methods for optimising protein production
CN113699124B (zh) * 2021-09-08 2022-04-12 北京大学 一种含非天然氨基酸蛋白的制备方法
EP4504926A2 (en) * 2022-04-08 2025-02-12 ABSCI Corporation Trna synthetases and methods of use thereof
WO2024199465A1 (en) * 2023-03-30 2024-10-03 The Chinese University Of Hong Kong Unnatural amino acid in cellulo synthesis for site-specific protein modification
CN120752342A (zh) * 2023-07-13 2025-10-03 深圳华大生命科学研究院 工程生物遏制系统及方法
CN120210144A (zh) * 2023-12-25 2025-06-27 康码（上海）生物科技有限公司 一种改造的氨酰-tRNA合成酶、核酸构建物以及基因工程菌株

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0417801A (pt) * 2003-12-18 2007-04-10 Scripps Research Inst incorporação seletiva de 5-hidroxitriptofano em proteìnas de células mamìferas
AU2005330514B2 (en) * 2004-10-27 2011-05-12 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
CA2706889C (en) 2007-09-20 2018-08-28 Riken Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same
GB2470770A (en) 2009-06-04 2010-12-08 Medical Res Council Incorporation of unnatural amino acids having an orthogonal functional group into polypeptides using orthogonal tRNA/tRNA synthetase pairs
US20120077186A1 (en) 2010-05-07 2012-03-29 Oregon Health & Science University Use of cysteine-derived suppressor trnas for non-native amino acid incorporation
GB201201100D0 (en) 2012-01-20 2012-03-07 Medical Res Council Polypeptides and methods

Also Published As

Publication number Publication date
BR112017008108A2 (pt) 2017-12-19
US10738339B2 (en) 2020-08-11
WO2016066995A1 (en) 2016-05-06
KR20170070238A (ko) 2017-06-21
CA2965085A1 (en) 2016-05-06
KR102516695B1 (ko) 2023-03-30
CN107002088B (zh) 2022-01-11
JP6843044B2 (ja) 2021-03-17
EP3212799B1 (en) 2019-04-17
CN107002088A (zh) 2017-08-01
JP2017532043A (ja) 2017-11-02
US20170356023A1 (en) 2017-12-14
JP2021035374A (ja) 2021-03-04
EP3212799A1 (en) 2017-09-06

Similar Documents

Publication Publication Date Title
GB201419109D0 (en) Incorporation of unnatural amino acids into proteins
IL249955B (en) A method for the computational design of proteins
EP3236772A4 (en) Methods of purifying recombinant proteins
LT3197472T (lt) Rekombinantinių baltymų be fenilalanino naudojimas gydant fenilketonuriją
IL251571A0 (en) Variable proteins comprising the cry1da1 amino acid sequence are activated by lepidopteran
GB201518792D0 (en) Production of proteins
IL249131A0 (en) A method for reducing the immunogenicity of protein and peptide
EP3288952A4 (en) Organotrifluoroborate mimics of amino acids and uses thereof
GB201608197D0 (en) Novel proteins
IL295361A (en) Efficient selectivity of recombinant proteins
GB2558968B (en) G Proteins
HUE060529T2 (hu) Eljárás psWANG linkerrel rendelkezõ peptidek elõállítására
IL252712A0 (en) Method for protein production
SG11201609739UA (en) Derivatives of dolaproine-dolaisoleuine peptides
IL277377B (en) Prohemostatic proteins for the treatment of bleeding
PL3402573T3 (pl) Kompozycja zawierająca aminokwasy
GB201621512D0 (en) Unnatural amino acids
GB201704922D0 (en) Methods of protein stapling
GB201415425D0 (en) Small molecule inhibitors of classiv bromodomain proteins
EP3302067A4 (en) Use of proteins to control molluscs
GB201504211D0 (en) Use of peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)